Ranbaxy Laboratories

News from other websites on Ranbaxy Laboratories

Interview - Cipla expects to double respiratory drug sales by 2020| Reuters

Jun 17, 2015 at 23:30 | Source: FirstPost

MUMBAI Generic drugmaker Cipla (CIPL.NS) expects sales from its respiratory portfolio to more than double by 2020 and remains on track to launch its potentially lucrative inhaler in Britain, its chief executive said.More than a decade after it made h...

Sun Pharma reports Q4 net profit at Rs 888 cr, Ranbaxy deal shrinks earnings

May 29, 2015 at 19:41 | Source: FirstPost

New Delhi: Sun Pharma today reported a consolidated net profit of Rs 888.05 crore for the fourth quarter ended 31 March 2015.The company had posted a net profit of Rs 1,587.12 crore for the same period of the previous fiscal.Net sales of the company ...

Sun Pharma maybe willing to shell out $7 bn on further acquisitions

Apr 28, 2015 at 12:22 | Source: FirstPost

Sun Pharmaceuticals Industries, emboldened by its takeover of domestic rival Ranbaxy Laboratories, is willing to spend as much as $7 billion on further acquisitions, bankers familiar with the generic drugmaker's strategy said.The just completed Ranba...

Daiichi Sankyo's misery ends, block deal to give company coup de grce

Apr 22, 2015 at 14:21 | Source: FirstPost

The Japanese drug major, Daiichi Sankyo, has madeamends for the huge mistake it committed in 2008 when it bought itself into the Indian generic drug manufacturer Ranbaxy Laboratories Ltd for a whopping $3.2 billion.The Singh brothers got the lions sh...

Daiichi Sankyo's misery ends, block deal to give co final coup de grce

Apr 22, 2015 at 12:58 | Source: FirstPost

The Japanese drug major, Daiichi Sankyo, has madeamends for the huge mistake it committed in 2008 when it bought itself into the Indian generic drug manufacturer Ranbaxy Laboratories Ltd for a whopping $3.2 billion.The Singh brothers got the lions sh...

Daiichi Sankyo's misery ends, block deal gives co the final coup de grce

Apr 22, 2015 at 11:07 | Source: FirstPost

The Japanese drug major, Daiichi Sankyo, has madeamends for the huge mistake it committed in 2008 when it bought itself into the Indian generic drug manufacturer Ranbaxy Laboratories Ltd for a whopping $3.2 billion.The Singh brothers got the lions sh...

Daiichi Sankyo to exit Sun Pharma, sell up its 9% stake for up to Rs 22,000 cr

Apr 21, 2015 at 08:45 | Source: FirstPost

Mumbai - Japan's Daiichi Sankyo Company Ltd is selling shares worth up to $3.6 billion or Rs 22,000 crore in Sun Pharmaceutical Industries Ltd, setting it on course to retreat from India after a roller-coaster seven years.Daiichi Sankyo bought India'...

Daiichi Sankyo to exit Sun Pharma, sell its 9% stake for up to Rs 22,000 cr

Apr 21, 2015 at 08:45 | Source: FirstPost

Mumbai - Japan's Daiichi Sankyo Company Ltd is selling shares worth up to $3.6 billion or Rs 22,000 crore in Sun Pharmaceutical Industries Ltd, setting it on course to retreat from India after a roller-coaster seven years.Daiichi Sankyo bought India'...

Japan's Daiichi Sankyo to exit Sun Pharma, sell up to $3.6 bn stake

Apr 21, 2015 at 00:00 | Source: FirstPost

Mumbai - Japan's Daiichi Sankyo Company Ltd is selling shares worth up to $3.6 billion in Sun Pharmaceutical Industries Ltd, setting it on course to retreat from India after a roller-coaster seven years.Daiichi Sankyo bought India's Ranbaxy Laborator...

Sensex edges down in cautious trade, Sun Pharma rises

Mar 25, 2015 at 15:06 | Source: FirstPost

Mumbai: The BSE Sensex and Nifty edged down on Wednesday to their near six-week lows and were heading for a sixth straight session of falls, as caution ahead of the expiry of monthly derivatives and the end of the fiscal year hit blue-chips such as L...

Sun Pharma gets RBI nod for transfer of Ranbaxy overseas investments

Mar 24, 2015 at 13:42 | Source: FirstPost

New Delhi: Sun Pharmaceutical Industries has received RBI nod for transfer of overseas investments of Ranbaxy to it and issue its shares to the non-resident shareholders of the latter as part of their $4 billion merger deal.In a filing to the BSE, Ra...

Sun Pharma third-quarter profit falls

Feb 14, 2015 at 21:30 | Source: FirstPost

MUMBAI (Reuters) - Sun Pharmaceutical Industries Ltd, India's largest drugmaker, said on Saturday third-quarter net profit fell unexpectedly due to a decline in sales in the United States and costs from resolving regulatory issues at a manufacturing ...

US Federal Trade Commission approves Sun Pharma's Ranbaxy acquisition

Feb 02, 2015 at 12:42 | Source: FirstPost

New Delhi: The US Federal Trade Commission (FTC) has completed its review of the proposed USD 4 billion acquisition of Ranbaxy Laboratories by Sun Pharma and granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improv...

Ipca hit by FDA ban over Ratlam plant production violations

Jan 25, 2015 at 00:15 | Source: FirstPost

MUMBAI (Reuters) - U.S. regulator the Food and Drug Administration has banned imports from a Madhya Pradesh manufacturing plant of generic drugmaker Ipca Laboratories Ltd(IPCA.NS), citing violations of standard production practices.India is second on...

Ipca Labs hit by FDA ban on MP plant for standard violations

Jan 23, 2015 at 11:54 | Source: FirstPost

The US Food and Drug Administration (FDA) has banned imports from Indian generic drugmaker Ipca Laboratories Ltd's plant at Ratlam in Madhya Pradesh due to violations of standard production practices.Ipca had voluntarily halted shipments to the Unite...

Double blow to Ranbaxy

Nov 07, 2014 at 12:42 | Source: Calcutta Telegraph News

Mumbai, Nov. 6: The US health regulator has revoked tentative approvals to Ranbaxy Laboratories to make the generic versions of AstraZeneca’s heartburn drug Nexium and Roche Holding’s anti-viral Valcyte. The tentative approvals to the tw...

US boost for Ranbaxy net

Oct 29, 2014 at 03:42 | Source: Calcutta Telegraph News

Mumbai, Oct. 28: Ranbaxy Laboratories today reported its first net profit in six quarters, gaining from the exclusive US launch of a cheaper copy of Novartis�s blood pressure pill Diovan. The drug firm, which is being bought by larger rival Sun Ph...

Cadila recalls drug in US

Oct 18, 2014 at 20:22 | Source: Calcutta Telegraph News

Mumbai, Oct. 17: Cadila Healthcare has voluntarily recalled 5,400 bottles of anti-hypertension drug Atenolol tablets in the US for failing to meet specifications. A notification by the US Food and Drug Administration (USFDA) said the recall was volu...

Ranbaxy buys Texas peace

Oct 17, 2014 at 12:32 | Source: Calcutta Telegraph News

Mumbai, Oct. 16: Ranbaxy Laboratories today said it would pay $39.75 million (Rs 244 crore) to the state of Texas in the US to settle the litigation with regard to its participation in a social health scheme meant for the poor. “The company ha...

Strides, Shasun pop merger pill

Sep 30, 2014 at 12:57 | Source: Calcutta Telegraph News

Mumbai, Sept: 29: Chennai-based Shasun Pharmaceuticals Ltd will be merged with generic drug maker Strides Arcolab to create a Rs 2,500-crore entity spanning across multiple segments. The merged entity will figure among the top 15 listed Indian pharm...

video of the day

Economy turning for sure but cant say for mkts: DSP

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.